BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2566145)

  • 1. Allelic variation of the c-raf-1 proto-oncogene in human lymphoma and leukemia.
    Trench GC; Southall M; Smith P; Kidson C
    Oncogene; 1989 Apr; 4(4):507-10. PubMed ID: 2566145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allelic variation of the c-raf-1 oncogene in non-Hodgkin's lymphoma.
    Chenevix-Trench G; Behm F; Westin E
    Leukemia; 1987 Jan; 1(1):82-6. PubMed ID: 2889852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EcoRI RFLP of c-mos in patients with non-Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non-geriatric controls.
    Chenevix-Trench G; Southall M; Kidson C
    Int J Cancer; 1989 Jun; 43(6):1034-6. PubMed ID: 2567285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frequency and rearrangements of alleles of proto-oncogene c-Ha-ras-1 and their association with development of various malignant tumors in man].
    Nikiforova IF; Serova OM; Pluzhnikova GF; Kniazev PG; Seĭts IF
    Genetika; 1990 Mar; 26(3):531-40. PubMed ID: 1972367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel restriction fragment length polymorphisms in the cellular oncogene SEA.
    Koduru PR; Goh JC; Broome JD
    Hematol Pathol; 1992; 6(2):71-8. PubMed ID: 1351480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of the human c-abl gene: relation to incidence and course of chronic myelogenous leukemia.
    Daniel L; Ahmed CM; Bloodgood RS; Kidd JR; Castiglione CM; Duttagupta S; Lebowitz P
    Oncogene; 1987 May; 1(2):193-200. PubMed ID: 2894000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic polymorphism and susceptibility to cancer].
    Larsen CJ
    Nouv Rev Fr Hematol (1978); 1988; 30(1-2):39-43. PubMed ID: 2898751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single point mutation responsible for c-mos polymorphism in cancer patients.
    Lidereau R; Cole ST; Larsen CJ; Mathieu-Mahul D
    Oncogene; 1987 May; 1(2):235-7. PubMed ID: 2894001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of the proto-oncogene ETS-1 in hematological malignancies.
    Kerckaert JP; Duterque-Coquillaud M; Collyn-d'Hooghe M; Morel P; Majérus MA; Laï JL; Fenaux P; Bauters F; Debuire B; Loucheux-Lefebvre MH
    Leukemia; 1990 Jan; 4(1):16-9. PubMed ID: 1967322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Ha-ras-1 polymorphism in human breast carcinomas: evidence for a normal distribution of alleles.
    Sheng ZM; Guerin M; Gabillot M; Spielmann M; Riou G
    Oncogene Res; 1988 Feb; 2(3):245-50. PubMed ID: 2897104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction fragment length polymorphism and activation of c-Ha-ras gene in urothelial cancer.
    Ishikawa J; Maeda S; Kamidono S; Sugiyama T
    Anticancer Res; 1988; 8(5A):915-24. PubMed ID: 2902823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogene activation in hematopoietic malignancies.
    Sherr CJ; Look AT
    Monogr Pathol; 1987; (29):225-48. PubMed ID: 2884561
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias.
    Aydin-Sayitoglu M; Hatirnaz O; Erensoy N; Ozbek U
    Am J Hematol; 2006 Mar; 81(3):162-70. PubMed ID: 16493615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosome translocations in B and T cell neoplasias.
    Showe LC; Croce CM
    Semin Hematol; 1986 Oct; 23(4):237-44. PubMed ID: 3535082
    [No Abstract]   [Full Text] [Related]  

  • 15. DNA restriction fragment length polymorphisms at either end of the c-raf-1 locus at 3p25.
    Graziano SL; Mark GE; Murray C; Mann DL; Ehrlich GD; Poiesz BJ; Weston A
    Oncogene Res; 1988; 3(1):99-103. PubMed ID: 2905034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the c-Ha-ras-1 locus polymorphism in an Italian population with high incidence of gastric cancer.
    Ranzani GN; Salerno-Mele P; Maltoni M; Talarico D; Della Valle G; Amadori D
    Mol Biol Med; 1988 Dec; 5(3):145-53. PubMed ID: 2907601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism within the second intron of the IL-1 receptor antagonist gene in patients with hematopoietic malignancies.
    Demeter J; Messer G; Rämisch S; Mee JB; di Giovine FS; Schmid M; Herrmann F; Porzsolt F
    Cytokines Mol Ther; 1996 Dec; 2(4):239-42. PubMed ID: 9384710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome and oncogene rearrangements in leukemia and lymphoma.
    Yunis JJ
    Monogr Pathol; 1986; (27):91-6. PubMed ID: 3762556
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amplification and rearrangement of proto-oncogene c-abl in human leukemia cells].
    Jin XM; Miao J; Xu Y; Deng GR
    Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):167-70. PubMed ID: 3219975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.